Xia G. Sheng
Hainan, China
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 41 publications
Environmental chemicals and the tumor immune microenvironment.
Journal: iMeta
Published: June 24, 2026
Environmental benzophenone exposure promotes liver cancer cell proliferation via the IRE1α-XBP1s pathway.
Journal: Food and chemical toxicology : an international journal published for the British Industrial Biological Research Association
Published: January 14, 2026
Environmental benzophenone exposure promotes breast cancer cell metastasis via the Wnt/β-catenin pathway.
Journal: Journal of hazardous materials
Published: October 31, 2025
Heterogeneous cellular responses to hyperthermia support combined intraperitoneal hyperthermic immunotherapy for ovarian cancer mouse models.
Journal: Science translational medicine
Published: March 12, 2025
Serum 25-hydroxyvitamin D, vitamin D-related variants, and risk of chronic liver disease.
Journal: International journal of cancer
Published: January 09, 2025
Integrated analysis of single-cell and bulk transcriptomics reveals cellular subtypes and molecular features associated with osteosarcoma prognosis.
Journal: BMC cancer
Published: October 17, 2024
Characterization of 3,3'-iminodipropionitrile (IDPN) damaged utricle transcriptome in the adult mouse utricle.
Journal: Frontiers in molecular neuroscience
Published: August 28, 2024
Author Correction: IRE1α-XBP1s pathway promotes prostate cancer by activating c-MYC signaling.
Journal: Nature communications
Published: July 23, 2024
Integrated single-cell transcriptomic analyses identify a novel lineage plasticity-related cancer cell type involved in prostate cancer progression.
Journal: EBioMedicine
Published: April 24, 2024
Environmental monobutyl phthalate exposure promotes liver cancer via reprogrammed cholesterol metabolism and activation of the IRE1α-XBP1s pathway.
Journal: Oncogene
Published: February 08, 2024
Integrated analysis of single-cell and bulk transcriptomics develops a robust neuroendocrine cell-intrinsic signature to predict prostate cancer progression.
Journal: Theranostics
Published: November 17, 2023
Last Updated: 09/26/2026